Nexomera Tablets 20 mg (Esomeprazole Magnesium Trihydrate)
Esomeprazole Magnesium Trihydrate 22.25mg
Tablet · Prescription medication
Jeongwoo Pharmaceutical Co., Ltd.
MFDS item code 201604088 · Approved 2016.06.29
Treatment and prevention of gastroesophageal reflux disease, ulcers and drug-induced gastrointestinal symptoms, and Zollinger-Ellison syndrome
This medication helps treat gastroesophageal reflux disease and erosive esophagitis and prevents recurrence. It is also used for the treatment and prevention of duodenal ulcers and peptic ulcers caused by Helicobacter pylori infection and alleviates abdominal pain or discomfort associated with the short-term use of non-steroidal anti-inflammatory drugs (NSAIDs). It is effective for the treatment and prevention of gastric and duodenal ulcers potentially caused by prolonged NSAID use. The medication may be used as maintenance therapy for Zollinger-Ellison syndrome and to prevent rebleeding from gastric or duodenal ulcers. Overall, it is utilized broadly in the treatment and prevention of gastrointestinal-related diseases.
This medicine should be swallowed with a liquid such as water and should not be chewed or crushed. 1. Adults 1) Gastroesophageal reflux disease (GERD). - Treatment of erosive reflux esophagitis: Administer 40 mg once daily for 4 weeks. For patients whose esophagitis has not healed or whose symptoms persist, continue treatment for an additional 4 weeks. - Long-term maintenance therapy to prevent recurrence in patients with esophagitis: 20 mg once daily - Symptomatic treatment of gastroesophageal reflux disease without esophagitis: · 20 mg once daily. If symptoms are not controlled after 4 weeks, further evaluation is required. · Once symptoms have resolved, subsequent recurring symptoms are controlled with 20 mg once daily. · In adults, 20 mg may be administered once daily as needed. As-needed administration is not recommended for control of recurring symptoms in patients at high risk of gastric and duodenal ulcers due to nonsteroidal anti-inflammatory drug treatment. 2) Combination therapy with antibiotics for Helicobacter pylori eradication Administer this medicine 20 mg with amoxicillin 1 g and clarithromycin 500 mg twice daily for 7 days. 3) Short-term treatment of upper gastrointestinal symptoms (pain, discomfort, burning sensation) associated with nonsteroidal anti-inflammatory drug (nonselective or selective COX-2) treatment - 20 mg once daily. If symptoms are not controlled after 4 weeks, further evaluation is required. Clinical trials exceeding 4 weeks have not been conducted. 4) Patients requiring continuous nonsteroidal anti-inflammatory drug treatment - Treatment of gastric ulcers associated with nonsteroidal anti-inflammatory drug treatment: 20 mg once daily. The treatment period is 4∼8 weeks. - Prevention of gastric and duodenal ulcers associated with nonsteroidal anti-inflammatory drug treatment: 20 mg once daily. 5) Treatment of Zollinger-Ellison syndrome The recommended initial dose is 40 mg twice daily. The dose should subsequently be adjusted for each patient, and treatment should continue while clinical symptoms are present. Clinical data indicate that most patients can be controlled with doses of 80 ∼ 160 mg daily. Doses greater than 80 mg daily should be divided into 2 doses. 6) Maintenance therapy following intravenous induction to prevent rebleeding from gastric or duodenal ulcers Administer 40 mg once daily for 4 weeks following intravenous induction to prevent rebleeding from gastric or duodenal ulcers. 4. Renal impairment No dose adjustment is required. Administer with caution because there is limited experience in patients with severe renal impairment. 5. Hepatic impairment No dose adjustment is required in patients with mild to moderate hepatic impairment. The dose should not exceed 20 mg in patients with severe hepatic impairment. 6. Elderly patients No dose adjustment is required.
2. Adolescents aged 12 years and older 1) Gastroesophageal reflux disease (GERD) - Treatment of erosive reflux esophagitis: Administer 40 mg once daily for 4 weeks. For patients whose esophagitis has not healed or whose symptoms persist, continue treatment for an additional 4 weeks. - Symptomatic treatment of gastroesophageal reflux disease without esophagitis: · 20 mg once daily. If symptoms are not controlled after 4 weeks, further evaluation is required. · Once symptoms have resolved, subsequent recurring symptoms are controlled with 20 mg once daily. · In adults, 20 mg may be administered once daily as needed. As-needed administration is not recommended for control of recurring symptoms in patients at high risk of gastric and duodenal ulcers due to nonsteroidal anti-inflammatory drug treatment. 3. Children under 12 years There is no experience with administration of this medicine to children under 12 years of age.
This medication should not be used in specific patients. For instance, patients who are allergic or have experienced hypersensitivity reactions to this medication or its components, patients allergic to certain antibiotics, patients currently taking specific heart-related medications, and breastfeeding females or patients with a history of myocardial infarction should not take this medication. This medication contains the pigment yellow No. 5, and patients with allergies or hypersensitivity to this ingredient should use it with caution. This medication may cause various side effects. Common symptoms include headache, abdominal pain, diarrhea, constipation, and nausea, while rare symptoms can include blood abnormalities, skin rashes, liver function abnormalities, muscle pain, and neurological symptoms. Serious side effects such as severe skin reactions or muscle damage have also been reported, and if symptoms appear, immediate consultation with medical personnel is required. Regular testing is necessary during long-term use, particularly if used for over one year, as electrolyte imbalances such as hypomagnesemia may occur; hence magnesium levels should be checked periodically. This medication may interact with other drugs; therefore, it is imperative to inform healthcare personnel about any medications currently being taken, particularly when using antiviral agents, anticoagulants, antibiotics, or anticonvulsants. If pregnant or breastfeeding, it is crucial to consult with a doctor before using this medication, and it is not recommended during breastfeeding. In the case of overdose, there is no specific antidote, so appropriate treatment should be administered according to symptoms, and it should be kept out of reach of children. When using this medication, it is essential to follow the doctor's instructions regarding the minimum dosage and appropriate duration of use.
Leukopenia, thrombocytopenia, agranulocytosis, pancytopenia, fever, angioedema, anaphylactic reaction, shock, peripheral edema, hyponatremia, hypomagnesemia, insomnia, anxiety, mental confusion, depression, aggression, hallucination, headache, dizziness, paresthesia, drowsiness, taste disturbance, blurred vision, bronchospasm, pancreatitis, abdominal pain, constipation, diarrhea, abdominal distension, nausea, vomiting, dry mouth, stomatitis, gastrointestinal candidiasis, microscopic colitis, increased liver enzymes, jaundice, hepatitis, liver failure, encephalopathy, dermatitis, itching, rash, urticaria, hair loss, photosensitivity, erythema multiforme, mucocutaneous syndrome, Stevens-Johnson syndrome, toxic epidermal necrolysis, acute generalized pustular psoriasis, eosinophilia and systemic symptoms-associated drug reaction, fracture, arthralgia, myalgia, muscle weakness, epilepsy nephritis, gynecomastia, asthenia, increased sweating, Clostridium difficile-associated diarrhea, abdominal distension, allergic reaction, back pain, chest pain, retrosternal pain, facial swelling, facial flushing, fatigue, fever, influenza-like symptoms, generalized edema, leg edema, malaise, pain, stiffness, peripheral edema, flushing, hypertension, tachycardia, goiter, irritable bowel syndrome, worsening constipation, dyspepsia, dysphagia, gastrointestinal motility disorders, epigastric pain, belching, esophageal disorders, frequent bowel movements, gastroenteritis, gastrointestinal bleeding, hiccups, black stools, oral disorders, pharyngeal disorders, rectal disorders, gastrointestinal symptoms, increased serum gastrin levels, tongue disorders, tongue swelling, ulcerative stomatitis, vomiting, earache, tinnitus, anemia, hypochromic anemia, cervical lymphadenopathy, nosebleed, leukocytosis, leukopenia, thrombocytopenia, hyperbilirubinemia, liver dysfunction, increased ALT, increased AST, diabetes, hyperuricemia, increased ALP, polydipsia, vitamin B12 deficiency, weight gain, weight loss, worsening arthritis, arthropathy, seizures, fibromyalgia syndrome, hernia, rheumatoid polymyalgia, arthralgia, loss of appetite, apathy, increased appetite, confusion, worsening depression, hypertonicity, anxiety, sensory loss, erectile dysfunction, insomnia, migraine, worsening migraine, sleep disorders, tremor, dizziness, visual field loss, paresthesia, drowsiness, dysmenorrhea, menstrual disorders, vaginitis, exacerbation of asthma, cough, dyspnea, laryngeal edema, pharyngitis, rhinitis, sinusitis, acne, anal itching, rash, erythematous rash, papular rash, angioedema, dermatitis, itching, urticaria, increased sweating, otitis media, hyposmia, ageusia, parageusia, urinary abnormalities, albuminuria, cystitis, dysuria, fungal infection, hematuria, urinary frequency, candidiasis, genital candidiasis, polyuria, conjunctivitis, visual disturbances, duodenitis, esophagitis, esophageal stricture, esophageal ulcer, esophageal varices, gastric ulcer, gastritis, benign polyp or nodule, Barrett's esophagus, mucosal discoloration, hernia, systemic lupus erythematosus, cutaneous lupus erythematosus, gastric fundic polyps, hypocalcemia, hypokalemia, rhabdomyolysis
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly closed container to avoid exposure to air or moisture. It is important to maintain storage temperatures between 1 degree and 30 degrees Celsius to safely preserve the effectiveness of the medication over time.
Pale pink round film-coated tablet
28 tablets (14 tablets/Alu-Alu X 2)
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Esomeprazole Magnesium Trihydrate 22.25mg
Tablet · Prescription medication
Jeongwoo Pharmaceutical Co., Ltd.

Esomeprazole Magnesium Trihydrate 44.5mg
Tablet · Prescription medication
AstraZeneca Korea Co., Ltd.

Esomeprazole Magnesium Trihydrate 22.3mg
Tablet · Prescription medication
AstraZeneca Korea Co., Ltd.

Esomeprazole Magnesium Trihydrate 22.3mg
Tablet · Prescription medication
Daewon Pharmaceutical Co., Ltd.

Esomeprazole Magnesium Trihydrate 44.5mg
Tablet · Prescription medication
Daewon Pharmaceutical Co., Ltd.

Esomeprazole Magnesium Dihydrate 43.38mg
Tablet · Prescription medication
Jongkundang Co., Ltd.

Esomeprazole Magnesium Dihydrate 21.69mg
Tablet · Prescription medication
Chong Kun Dang Pharmaceutical Corp.

Esomeprazole Magnesium Trihydrate 22.3mg
Tablet · Prescription medication
Samjin Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.